RecallReported November 4, 2026
Class II recall by Glenmark Pharmaceuticals Inc., USA
Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC…
FDA's enforcement report of November 4, 2026 lists a Class II recall by Glenmark Pharmaceuticals Inc., USA of Elmwood Park, NJ. Product: Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC…. Status: Ongoing.
On the record
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- Location
- Elmwood Park, NJ
- Classification
- Class II
- Status
- Ongoing
- Recall number
- D-0074-2027
- Product type
- Drugs
- Brand names
- ABIRATERONE ACETATE
- Generic names
- ABIRATERONE ACETATE
- Recall initiated
- 2026-10-09
- Reported by FDA
- 2026-11-04
The full record
An account shows the reason for the recall, where the product was distributed and the lots.
What a recall is
FDA classifies a recall by the hazard. Class I: a reasonable probability that the product will cause serious adverse health consequences or death. Class II: the product may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III: the product is not likely to cause adverse health consequences.
More
Watch Glenmark Pharmaceuticals Inc., USA
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA enforcement reports. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Glenmark Pharmaceuticals Inc., USA.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.